sponsored
PatientsVille.com Logo

PatientsVille

Bronkaid Dual Action Caplets Medical Research Studies

Up-to-date List of Bronkaid Dual Action Caplets Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Bronkaid Dual Action Caplets Medical Research Studies

Rank Status Study
1 Recruiting Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
Conditions: Major Depressive Disorder;   Minor Depressive Disorder;   Sub-Threshold Depression;   Diabetes Mellitus
Interventions: Behavioral: Step 1: Diabetes-Specific CBT (5 group sessions);   Behavioral: Step 2: Depression-Specific CBT (6 single sessions);   Behavioral: Step 3: Referral to Psychotherapist and/or Psychiatrist;   Behavioral: Standard Diabetes Education
Outcome Measures: Depressive Mood - Hamilton Rating Scale for Depression (HAMD);   Diabetes-Related Distress - The Problem Areas in Diabetes Questionnaire (PAID);   Psychological/ Emotional Well-Being - The WHO-5 Well-being Index (WHO-5);   Health-Related Quality of Life - The Short Form-36 Health Survey (SF-36);   Diabetes Self-Care Behavior - The Summary of Diabetes Self-Care Activities Measure (SDSCA);   Glycaemic Control (HbA1c);   Health-Related Quality of Life - The EuroQol-5D (EQ-5D);   Diabetes Self-Care Behavior - The Diabetes Self-Management Questionnaire (DSMQ)
2 Recruiting Diabetes and Partnership: Evaluation of a Diabetes Education Module
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Partnership
Outcome Measures: Change from baseline in diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
3 Recruiting Diabetes and Sports: Evaluation of a Diabetes Education Module
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Sports
Outcome Measures: Change from baseline in diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in physical activity on the International Physical Activity Questionnaire (IPAQ) at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up;   Change from baseline in hypoglycemia awareness at the 2-week and 6-month follow-up;   Change from baseline in self-care behaviors at the 2-week and 6-month follow-up
4 Recruiting Diabetes and Travel: Evaluation of a Diabetes Education Module - a Randomized Controlled Trial (PRIMO_Travel)
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Travel
Outcome Measures: Change from baseline in diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
5 Recruiting Diabetes and Social Issues: Evaluation of a Diabetes Education Module
Condition: Diabetes Mellitus
Intervention: Behavioral: Education - Diabetes and Social Issues
Outcome Measures: Change from baseline in diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up;   Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up;   Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up;   Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up;   Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up;   Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up;   Change from baseline in general diabetes-distress at the 2-week and 6-month follow-up;   Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up
6 Not yet recruiting Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Condition: Diabetes Mellitus Type 2
Intervention: Other: diabetes self management support
Outcome Measures: Change from baseline HbA1c at 3, 9, 15, and 27 months;   Change from baseline blood pressure at 3, 9, 15, and 27 months;   Change from baseline cholesterol at 3, 9, 15, and 27 months;   Change from baseline BMI at 3, 9, 15, and 27 months;   Change from baseline weight at 3, 9, 15, and 27 months;   Change from baseline fasting glucose at 3, 9, 15, and 27 months;   Change from baseline diabetes knowledge at 3, 9, 15, and 27 months;   Change from baseline diabetes self-care behavior at 3, 9, 15, and 27 months;   Change from baseline diabetes-specific quality of life at 3, 9, 15, and 27 months;   Change from baseline health-related quality of life at 3, 9, 15, and 27 months;   Change from baseline depression at 3, 9, 15, and 27 months;   Change from baseline food security at 3, 9, 15, and 27 months
7 Unknown  Educational Intervention and Social Support in Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Other: Educational intervention for family members/caregivers of people with Diabetes Mellitus through telephone contact;   Other: Educational intervention group for people with diabetes through Diabetes Conversation Maps
Outcome Measures: glycated hemoglobin;   fasting plasma glucose;   triglycerides;   total cholesterol and fractions;   microalbuminuria;   urea;   creatinine;   body mass index;   waist circumference;   blood pressure;   Perceived Self-Efficacy: Diabetes Management Self-efficacy Scale for Patients with Type 2 Diabetes Mellitus;   Knowledge about Diabetes Mellitus: Diabetes Mellitus knowledge (DKN-A);   Adherence to medication treatment: Self-Reported Measure of Medication Adherence (Measure of Treatment Adherence - MTA);   Adherence to self care: Summary of Diabetes Self-Care Activities Questionnaire (SDSCA) ( Diabetes Self-Care Activities Questionnaire);   Perception of stress: Perceived Stress Scale (Perceived Stress Scale);   Ways of coping: Ways of Coping Scale (Ways of Coping Scale);   Acceptance of Illness (Acceptance of Illness Scale);   Perception of social support: The Social Support Network Inventory;   Self-monitoring of blood glucose
8 Recruiting Non-Alcoholic Fatty Liver Disease in Gestational Diabetes
Condition: Gestational Diabetes Mellitus in Pregnancy
Interventions: Other: Subjects with Gestational Diabetes;   Other: Controls without Gestational Diabetes
Outcome Measures: Percentage of patients with NAFLD and gestational diabetes.;   Insulin sensitivity expressed as the Matsuda Index, measured during an oral glucose tolerance test.
9 Recruiting Lifestyle Intervention for Treatment of Diabetes
Conditions: Type 2 Diabetes;   Overweight;   Obesity
Interventions: Behavioral: Community Lifestyle Weight Loss (LWL);   Behavioral: Diabetes Self Management (DSM)
Outcome Measures: Predicted Cardiovascular Risk;   Hemoglobin A1c;   Blood Pressure;   Lipids;   Weight Change
10 Recruiting Effectiveness Study of Interactive Web Application for Problem Solving in Diabetes Management
Condition: Diabetes Mellitus
Interventions: Behavioral: Early Mobile Diabetes Detective (MoDD);   Behavioral: Late Mobile Diabetes Detective (MoDD)
Outcome Measures: Change in HgA1c;   Change in Score on the Diabetes Problem-Solving Inventory (DPSI);   Change in Score on the Summary of Diabetes Self-Care Activities Questionnaire (SDSCA);   Change in Score on Problem Areas in Diabetes Scale (PAID);   Change in Score on the Diabetes Self-Efficacy Scale (DSES);   Change in Score on the Patient Health Questionnaire-2 (PHQ-2);   Change in Fasting Blood Glucose Level;   Change in Total Cholesterol;   Change in Blood Pressure;   Change in High-Density Lipoprotein;   Change in Low-Density Lipoprotein
11 Not yet recruiting Web-Based Collaborative Care for Patients With Diabetes and Depression
Conditions: Diabetes Mellitus, Type 2;   Depression
Interventions: Device: web-based collaborative care;   Other: wait-list;   Behavioral: usual diabetes outpatient care
Outcome Measures: Change in Patient Health Questionnaire-9 items (PHQ-9) score;   Change in biochemical index;   Chang in quality of life (EuroQol-5D)score;   Change in Diabetes-specific stress;   Change in Health behaviours;   Change in general self-efficacy
12 Unknown  Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Diabetes Transitions Tool Kit
Outcome Measures: Glycemic Control;   Diabetes Distress;   Diabetes Self-Management;   Unplanned Readmission or ED visit
13 Unknown  Diabetes Mellitus Community Based Screening in Minority Populations
Conditions: Type II Diabetes;   Diabetes Mellitus
Interventions: Behavioral: Education on risk factors for Type II Diabetes;   Behavioral: Education on Type II Diabetes;   Behavioral: Education on regular visits to a Primary Care Provider
Outcome Measure:
14 Unknown  Parental Management of Young Children's Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Parental Support;   Behavioral: Diabetes Education
Outcome Measures: Glycemic variability;   Parent Quality of Life;   Child Quality of Life;   Hemoglobin A1C
15 Recruiting Prospective Cohort Study of the Body Constitution Among Type II Diabetes Mellitus Patients
Condition: Diabetes Mellitus
Intervention:
Outcome Measures: Body constitution of type II Diabetes Mellitus patients;   All cause mortality of type II Diabetes Mellitus patients;   Life quality of diabetes mellitus patients;   Diabetic retinopathy of type II Diabetes Mellitus patients;   Diabetic nephropathy of type II Diabetes Mellitus patients;   Diabetic neuropathy of type II Diabetes Mellitus patients
16 Unknown  A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care
Conditions: Type 2 Diabetes;   Major Depressive Disorder
Interventions: Behavioral: Diabetes and depression intervention;   Behavioral: Diabetes intervention
Outcome Measures: Glycosylated Hemoglobin;   Quick Inventory of Depressive Symptoms - Self Report
17 Not yet recruiting Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women
Condition: Gestational Diabetes Mellitus
Intervention:
Outcome Measure: Long term effects of gestational Diabetes Mellitus in a population of parous women
18 Recruiting mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study
Conditions: Phone Cognitive Behavioral Therapy;   Smartphone App
Interventions: Behavioral: CBT;   Device: Smartphone app;   Other: Standard Diabetes Care at PCP
Outcome Measures: acceptability questionnaire;   MEMS cap electronic pill bottle;   diabetes distress scale;   Medication Beliefs Scale;   HbA1c level;   Body Mass Index
19 Not yet recruiting Resilient, Empowered, Active Living: REAL Diabetes Study
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Interventions: Behavioral: Resilient, Empowered, Active Living with Diabetes;   Behavioral: Information Control
Outcome Measures: Glycated hemoglobin (HbA1C);   Audit of Diabetes-Dependent Quality of Life (ADD-QoL);   Problem Areas in Diabetes (PAID) Scale - Short Form;   Patient Health Questionnaire-8 (PHQ-8);   Satisfaction With Life Scale (SWLS);   Summary of Diabetes Self-Care Activities (SDSCA)
20 Unknown  Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Intervention:
Outcome Measures: Change of insulin sensitivity (M-Value);   Change of insulin secretion;   Incidence of any diabetic complication

These studies may lead to new treatments and are adding insight into Bronkaid Dual Action Caplets etiology and treatment.

A major focus of Bronkaid Dual Action Caplets research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Bronkaid Dual Action Caplets